Have a personal or library account? Click to login
Pulmonary rehabilitation following the 2019 novel Coronavirus infection Cover

Pulmonary rehabilitation following the 2019 novel Coronavirus infection

Open Access
|Dec 2021

References

  1. 1. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic char-acterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The lancet. 2020;395: 565–574.10.1016/S0140-6736(20)30251-8
  2. 2. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) Outbreak – An Update on the Status. Military Medical Research. 2020;7: 11.10.1186/s40779-020-00240-0706898432169119
  3. 3. World Health Organization. Novel coronavirus–China. Available from: https://www.who.int/csr/don/12-january-2020-novel-corona-virus-china/en/. Accessed 11 March 2020.
  4. 4. World Health Organization. WHO characterizes COVID-19 as a pandemic - 11 March 2020. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/events-as-they-happen. Accessed 17 March 2020.
  5. 5. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents. 2020;55: 105924.10.1016/j.ijantimicag.2020.105924712780032081636
  6. 6. World Health Organization. Coronavirus Disease (COVID-19) pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 17 September 2020.
  7. 7. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GV, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology. 2004;203: 631–637.10.1002/path.1570716772015141377
  8. 8. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCOV infection. Frontiers of Medicine. 2020;14: 185–192.10.1007/s11684-020-0754-0708873832170560
  9. 9. Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: Clinical practice recommendations. Journal of Physiotherapy. 2020; 66: 73–82.10.1016/j.jphys.2020.03.011716523832312646
  10. 10. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): A clinical update. Frontiers of Medicine. 2020;14: 126–135.10.1007/s11684-020-0767-8711534832240462
  11. 11. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Canadian Journal of Ophthalmology. 2020;55: e125–e129.10.1016/j.jcjo.2020.03.003712428332284146
  12. 12. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: Common findings in COVID-19 patients. The Laryngo-scope. 2020;130: 1787.10.1002/lary.28692722830432237238
  13. 13. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infectious Diseases of Poverty. 2020;9: 29.10.1186/s40249-020-00646-x707952132183901
  14. 14. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the Cytokine Storm’ in COVID-19. Journal of Infection. 2020;80: 607–613.10.1016/j.jinf.2020.03.037719461332283152
  15. 15. Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turkish Journal of Medical Sciences. 2020;50: 611–619.10.3906/sag-2004-145719597932293834
  16. 16. Stringer KA, Puskarich MA, Kenes MT, Dickson RP. COVID-19: The uninvited guest in the intensive care unit - Implications for pharmacotherapy. Pharmacotherapy. 2020;40: 382–386.10.1002/phar.2394726206832267979
  17. 17. Wujtewicz M, Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - What should anaethesiologists and intensivists know about it?. Anaesthesiology Intensive Therapy. 2020;52: 34–41.10.5114/ait.2020.9375632191830
  18. 18. Chan KS, Zheng JP, Mok YW, Li YM, Liu YN, Chu CM, et al. SARS: Prognosis, outcome and sequelae. Respirology. 2003;8 Suppl: S36–S40.10.1046/j.1440-1843.2003.00522.x716921315018132
  19. 19. Lee AM, Wong JG, McAlonan GM, Cheung V, Cheung C, Sham PC, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. The Canadian Journal of Psychiatry. 2007;52: 233–240.10.1177/07067437070520040517500304
  20. 20. Landry MD, Geddes L, Moseman AP, Lefler JP, Raman SR, et al. Early reflection on the global impact of COVID19, and implications for physiotherapy. Physiotherapy. 2020;107: A1–A3.10.1016/j.physio.2020.03.003719493332312528
  21. 21. Levy J, Léotard A, Lawrence C, Paquereau J, Bensmail D, Annane D, et al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments following severe COVID-19. Annals of Physical and Rehabilitation Medicine. 2020;63: 376–378.10.1016/j.rehab.2020.04.002716526632315800
  22. 22. Kiekens C, Boldrini P, Andreoli A, Avesani R, Gamna F, Grandi M, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. “Instant Paper from the Field” on rehabilitation answers to the COVID-19 emergency. European Journal of Physical and Rehabilitation Medicine. 2020;56: 323–326.10.23736/S1973-9087.20.06305-432293817
  23. 23. Carda S, Invernizzi M, Bavikatte G, Bensmail D, Bianchi F, Deltombe T, et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Annals of Physical and Rehabilitation Medicine. 2020;S1877–0657: 30076–30082.10.1016/j.rehab.2020.04.001716601832315802
  24. 24. Stam HJ, Stucki G, Bickenbach J. Covid-19 and post intensive care syndrome: A call for action. Journal of Rehabilitation Medicine. 2020;52: jrm00044.10.2340/16501977-2677
  25. 25. Khan F, Amatya B. Medical rehabilitation in pandemics: Towards a new perspective. Journal of Rehabilitation Medicine. 2020;52: jrm00043.10.2340/16501977-2676
  26. 26. Shang Y, Xu C, Jiang F, Huang R, Li Y, Zhou Y, et al. Clinical characteristics and changes of chest CT features in 307 patients with common COVID-19 pneumonia infected SARS-CoV-2: A multicenter study in Jiangsu, China. International Journal of Infectious Diseases. 2020;96: 157–162.10.1016/j.ijid.2020.05.006
  27. 27. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. The Lancet Infectious Diseases. 2020;20: 425–434.10.1016/S1473-3099(20)30086-4
  28. 28. Chinese Association of Rehabilitation Medicine; Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43: 308–314.
  29. 29. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary Therapies in Clinical Practice. 2020;39: 101166.10.1016/j.ctcp.2020.101166711859632379637
  30. 30. Li X, Ma X. Acute respiratory failure in COVID-19: Is it “Typical” ARDS? Critical Care. 2020;24: 198.10.1186/s13054-020-02911-9
  31. 31. Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020;12: e7560.10.7759/cureus.7560713842332269893
  32. 32. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020;55: 2001217.10.1183/13993003.01217-2020723682632381497
  33. 33. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz- Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine. 2011;364: 1293–1304.10.1056/NEJMoa101180221470008
  34. 34. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. New England Journal of Medicine. 2003;348: 683–693.10.1056/NEJMoa02245012594312
  35. 35. Wilcox ME, Herridge MS. Lung function and quality of life in survivors of the acute respiratory distress syndrome (ARDS). La Presse Mediale. 2011;40: e595–e603.10.1016/j.lpm.2011.04.02422078086
  36. 36. Yang LL, Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). Chronic Diseases and Translational Medicine. 2020;6: 79–86.10.1016/j.cdtm.2020.05.002722140632411496
  37. 37. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382: 1708–1720.10.1056/NEJMoa2002032709281932109013
  38. 38. Brodsky MB, Nollet JL, Spronk PE, González-Fernández M. Prevalence, pathophysiology, diagnostic modalities and treatment options for dysphagia in critically ill patients. American Journal of Physical Medicine & Rehabilitation. 2020;99: 1164–1170. doi: 10.1097/PHM.0000000000001440.10.1097/PHM.000000000000144032304381
  39. 39. Brugliera L, Spina A, Castellazzi P, Climino P, Tettamanti A, Houdayer E, et al. Rehabilitation of COVID-19 patients. Journal of Rehabilitation Medicine. 2020;52: jrm00046.10.2340/16501977-267832286674
  40. 40. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. Journal of Cardiovascular Electrophysiology. 2020;31: 1003–1008.10.1111/jce.14479726215032270559
  41. 41. Barker-Davies RM, O’Sullivan O, Senaratne KP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. British Journal of Sports Medicine. 2020;54: 949–959.10.1136/bjsports-2020-102596741862832475821
  42. 42. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology. 2020;77: 1–9.10.1001/jamaneurol.2020.1127714936232275288
  43. 43. Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu- Rumeileh S, Piscagilia MG, et al. Guillain-Barré syndrome following COVID-19: New infection, old complication?. Journal of Neurology. 2020;267: 1877–1879.10.1007/s00415-020-09849-6718064632333166
  44. 44. Andrenelli E, Negrini F, de Sire A, Arienti C, Patrini M, Negrini S, et al. Systematic rapid living review on rehabilitation needs due to COVID-19: Update to May 31st, 2020. European Journal of Physical and Rehabilitation Medicine. 2020;56: 508–514.10.23736/S1973-9087.20.06435-732539312
  45. 45. Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, et al. Post-intensive care syndrome: Its patho-physiology, prevention, and future directions. Acute Medicine & Surgery. 2019;6: 233–246.10.1002/ams2.415660331631304024
  46. 46. Smith JM, Lee AC, Zeleznik H, Coffey Scott JP, Fatima A, Needham DM, et al. Home and community-based physical therapist management of adults with post–intensive care syndrome. Physical Therapy. 2020;100: 1062–1073.10.1093/ptj/pzaa059
  47. 47. Piva S, Fagoni N, Latronico N. Intensive care unit–acquired weakness: Unanswered questions and targets for future research. F1000Research. 2019;8: F1000 Faculty Rev-508.10.12688/f1000research.17376.1
  48. 48. Schreiber A, Bertoni M, Goligher EC. Avoiding respiratory and peripheral muscle injury during mechanical ventilation dia-phragm-protective ventilation and early mobilization. Critical Care Clinics. 2018;34: 357–381.10.1016/j.ccc.2018.03.005
  49. 49. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology. 2020;92: 552–555.10.1002/jmv.25728
  50. 50. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 Pandemic. The Lancet Psychiatry. 2020;7: 611–627.10.1016/S2215-0366(20)30203-0
  51. 51. Connolly B, Salisbury L, O’Neill B, Geneen LJ, Douiri A, Grocott MP, et al. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness. Cochrane Database of Systematic Reviews. 2015;2015: CD008632.10.1002/14651858.CD008632.pub2651715426098746
  52. 52. Tipping CJ, Harrold M, Holland A, Romero L, Nisbet T, Hodgson CL. The effects of active mobilisation and rehabilitation in ICU on mortality and function: A systematic review. Intensive Care Medicine. 2017;43: 171–183.10.1007/s00134-016-4612-027864615
  53. 53. Fuke R, Hifumi T, Kondo Y, Hatakeyama J, Takei T, Yamakawa K, et al. Early rehabilitation to prevent postintensive care syndrome in patients with critical illness: A systematic review and meta- analysis. BMJ Open. 2018;8: e019998.10.1136/bmjopen-2017-019998594243729730622
  54. 54. Cuthbertson BH, Rattray J, Campbell MK, Gager M, Roughton S, Smith A, et al. The PRaCTICaL Study of Nurse Led, intensive care follow-up programmes for improving long-term outcomes from critical illness: A pragmatic randomised controlled trial. BMJ. 2009;339: b3723.10.1136/bmj.b3723276307819837741
  55. 55. Godeau E, Debeaumont D, Artaud-Macari E, Lagache L, Bouar GL, Coquart J. Sequelae of acute respiratory distress syndrome: Interest of rehabilitation. Case Reports in Critical Care. 2019;2019: 7953141.10.1155/2019/7953141643138930963009
  56. 56. Hsieh MJ, Lee WC, Cho HY, Wu MF, Hu HC, Kao KC, et al. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza and Other Respiratory Viruses. 2018;12: 643–648.10.1111/irv.12566608685429676537
  57. 57. Jackson J, Ely EW, Morey MC, Anderson VM, Siebert CS, Denne LB, et al. Cognitive and physical rehabilitation of intensive care unit survivors: Results of the RETURN randomized controlled pilot investigation. Critical Care Medicine. 2012;40: 1088–1097.10.1097/CCM.0b013e3182373115375587122080631
  58. 58. Gordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: A systematic review and meta- analysis. Chest. 2019;156: 80–91.10.1016/j.chest.2019.04.00931034818
  59. 59. Panagioti M, Scott C, Blakemore A, Coventry PA. Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 2014;9: 1289–1306.10.2147/COPD.S72073
  60. 60. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Pulmonary Rehabilitation. Thorax. 2001;56: 827–834.10.1136/thorax.56.11.827174595511641505
  61. 61. Rochester CL. Patient assessment and selection for pulmonary rehabilitation. Respirology. 2019;24: 844–853.10.1111/resp.1361631251443
  62. 62. Simpson R, Robinson L. Rehabilitation after critical illness in people with COVID-19 infection. American Journal of Physical Medicine & Rehabilitation. 2020;99: 470–474.10.1097/PHM.0000000000001443725303932282359
  63. 63. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2013;188: e13–e64.
  64. 64. Aitken LM, Marshall AP. Monitoring and optimising outcomes of survivors of critical illness. Intensive and Critical Care Nursing. 2015;31: 1–9.10.1016/j.iccn.2014.10.00625466983
  65. 65. Major ME, Kwakman R, Kho ME, Connolly B, McWilliams D, Denehy L, et al. Surviving critical illness: What is next? An expert consensus statement on physical rehabilitation after hospital discharge. Critical Care. 2016;20: 354.10.1186/s13054-016-1508-x508605227793165
  66. 66. Sheehy LM. Considerations for post-acute rehabilitation for survivors of COVID-19. JMIR Public Health Surveillance. 2020;6: e19462.10.2196/19462721281732369030
  67. 67. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis. Aging (Albany NY). 2020;12: 6049–6057.10.18632/aging.103000718511432267833
  68. 68. Hornikx M, Van Remoortel H, Demeyer H, Marcal Camillo CA, Decramer M, Janssens W, et al. The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: A systematic review. BioMed Research International. 2013;2013: 146148.10.1155/2013/146148388870624490146
  69. 69. Vitacca M, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, et al. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: The Italian position paper. Respiration. 2020;99: 493–499.10.1159/000508399731666432428909
  70. 70. Arcuri JF, Abarshi E, Preston NJ, Brine J, Di Lorenzo VA. Benefits of interventions for respiratory secretion management in adult palliative care patients - A systematic review. BMC Palliative Care. 2016;15: 74.10.1186/s12904-016-0147-y497911727507303
  71. 71. Gauld LM. Airway clearance in neuromuscular weakness. Developmental Medicine & Child Neurology. 2009;51: 350–355.10.1111/j.1469-8749.2008.03198.x
  72. 72. Volsko TA. Airway clearance therapy: Finding the evidence. Respiratory Care. 2013;58: 1669–1678.10.4187/respcare.0259024064626
  73. 73. Stephens RJ, Haas M, Moore III WL, Emmil JR, Sipress JA, Williams A. Effects of diaphragmatic breathing patterns on balance: A preliminary clinical trial. Journal of Manipulative Physiological Therapeutics. 2017;40: 169–175.10.1016/j.jmpt.2017.01.00528259495
  74. 74. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295: 715–721.10.1148/radiol.2020200370723336732053470
  75. 75. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68 Suppl 2: ii1–ii30.10.1136/thoraxjnl-2013-20380823880483
  76. 76. Macht M, White SD, Moss M. Swallowing dysfunction after critical illness. Chest. 2014;146: 1681–1689.10.1378/chest.14-1133425162325451355
  77. 77. Allingstrup MJ, Kondrup J, Wiis J, Claudius C, Pedersen UG, Hein-Rasmussen R, et al. Early goal-directed nutrition versus standard of care in adult intensive care patients: The single-centre, randomised, outcome assessor-blinded EAT-ICU trial. Intensive Care Medicine. 2017;43: 1637–1647.10.1007/s00134-017-4880-328936712
  78. 78. Lambell KJ, King SJ, Forsyth AK, Tierney AC. Association of energy and protein delivery on skeletal muscle mass changes in critically ill adults: A systematic review. JPEN Journal of Parenteral and Enteral Nutrition. 2018;42: 1112–1122.10.1002/jpen.115129603281
  79. 79. Rengel KF, Hayhurst CJ, Pandharipande PP, Hughes CG. Long-term cognitive and functional impairments after critical illness. Anesthesia & Analgesia. 2019;128: 772–780.10.1213/ANE.000000000000406630883422
  80. 80. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, et al. Evidence-based cognitive rehabilitation: Updated review of the literature from 1998 through 2002. Archives of Physical Medicine and Rehabilitation. 2005;86: 1681–1692.10.1016/j.apmr.2005.03.02416084827
DOI: https://doi.org/10.2478/pneum-2021-0013 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 197 - 208
Published on: Dec 7, 2021
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2021 Safae El Haddaoui, Youssra Amekran, Abdelkader Jalil El Hangouche, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.